FOR INVESTOR RELATIONS
PIONEERING THE MODULAR CORRECTION PLATFORM
THORACOLUMBAR SPINE FUSION SURGERY
INTRAOPERATIVE CORRECTION, REDEFINED
Axis Spine Technologies is advancing spinal alignment through modular precision – marketing an intraoperative correction platform including an FDA-cleared ALIF system for labeled lumbar indications and a broader thoracolumbar development pipeline.
Its platform provides surgeons with independent intraoperative control of lordosis, foraminal height, and coronal plane options, as well as patient anatomy-matching endplates – each selected at the moment when the surgeon has the fullest understanding of the patient’s anatomy and surgical requirements: in the operating room when the patient anatomy is known and the disc preparation is complete.
Supported by peer-reviewed biomechanical data and early clinical evidence, and protected by granted broad intellectual property spanning the thoracolumbar interbody space, Axis is building a differentiated modular lumbar interbody platform, including the FDA-cleared Axis Modular ALIF System for its labeled indications.
Axis is in its platform validation phase and currently raising capital to support continued platform development, clinical evidence generation, and strategic partnering activity.
(k)
FDA Cleared
+
US procedures
Patents Granted
US, EU, UK, Australia
$
B
TAM
Global Interbody Fusion Market
$
M
SAM
Series-B Unlocked Serviceable Addressable Market
SERIES B platform DEVELOPMENT RAISE
INVESTMENT MATERIALS UPON REQUEST
For Investor Relations contact us through: ir@axisspinetech.com
BACKED BY




LEADERSHIP & BOARD
Chairman & Board
Chaired by Simon Cartmell — who led ApaTech, a UK based, US focused spinal orthobiologics business to a $325M acquisition by Baxter and subsequently served as an Operating Partner at a leading UK life sciences venture fund — Axis is backed by a Board with extensive medical device operating, investment, and exit experience.
Executive Team
The executive team brings together deep spine expertise, US commercial experience, medical device finance, and proven transaction capability.
Jeff Cambra (Chief Executive Officer) brings over 28 years of global leadership experience across medical devices, biologics, and pharmaceuticals, with a track record spanning corporate strategy, fundraising, commercialization, M&A, and value creation.
Alex Williams (Chief Financial & Operating Officer) brings over 20 years of leadership experiences across venture-backed life sciences and medical technology companies, with a track record spanning fundraising, operational transformation, strategic growth, and exit.
Marc Sanders (Chief Technology Officer) has worked in the spinal industry for over 25 years in senior leadership roles at both multinationals and start up companies in 5 different countries. Marc has a proven track record turning around teams and successfully delivering significant portfolios in the areas of product development, new product introduction, clinical, marketing, and strategy.
Ivo Scheepens (VP Marketing & Professional Affairs) brings 25+ years of commercial leadership in global orthopaedics and spine — including a Medtronic MIS spine platform launch and a first-to-market PMA approval at a U.S. spine startup.
Patrick McDonough (VP US Market Development) brings 20+ years of commercial leadership experience in the spine industry with a track-record of positioning and launching novel solutions in highly competitive market segments.






